GH · Healthcare · Diagnostics & Research
Guardant Health’s Trend Signal turns back on at 97% of its yearly range, despite 0.9x volume
The precision-oncology diagnostics stock added 4.8% in the latest week and is now 2.0% below its 52-week high, but participation has not yet matched the strength of the price move.
131.6 USDLatest Close
4.8%1W Return
38.7%4W Return
54.5%12W Return